AAPP Scientific Poster Session Abstracts

Browse abstracts for all scientific posters that have been presented at the AAPP Annual Meeting.

Use the search box to quickly locate an abstract by any data in the column, including "PGY2"! The site search provides full-text search of all abstracts that have been presented at the AAPP Annual Meeting over the years.

Browse: 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025

Currently Viewing Abstracts from 2007

Title
A Comparison of Mental Illness Prevalence and Treatment Patterns Between Foster and Non-Foster Children within the Texas Medicaid System
A Multi-Attribute Decision Making Model to Aid in the Selection of Mood Stabilizing Medications for the Treatment of Bipolar Disorder
A Retrospective Evaluation of Olanzapine and Risperidone Effects on Metabolic Factors in Children and Adolescents
A RETROSPECTIVE EVALUATION OF PHYSICIAN PRESCRIBING HABITS IN CHILDREN AND ADOLESCENTS WITH MENTAL RETARDATION AND BIPOLAR DISORDER
A review of the safety and tolerability of treatments for moderate to severe AD
Ability to Manage Medication Regimen Affected by Depressive Symptoms and Medical Burden
ADHD SYMPTOM IMPROVEMENT IN CHILDREN TREATED WITH LISDEXAMFETAMINE DIMESYLATE: CGI
Adverse drug events in the geriatric population as a result of potentially inappropriate medication prescribing
Agranulocytosis related to concurrent clozapine and peg-interferon therapy.
Anticholinergic effects of complex medication therapy regimens in chronically, severely, mentally ill patients at a state psychiatric health-care facility
Application of Pharmaceutical Care Principles in Minimizing Cardiovascular Adverse Effects of Atypical Antipsychotic Drugs in a Community Mental Health Facility
Appropriateness of Quetiapine Utilization in a 400-bed Community Hospital
Aripiprazole augmentation in patients with severe and persistent mental illness
ARIPIPRAZOLE AUGMENTATION TO CLOZAPINE IN REFRACTORY SCHIZOPHRENIA
Aripiprazole-Induced Peripheral Edema: A Case Report
Assessment of Medication Management and Medication Education Groups in an Acute Psychiatric Facility
Association between the Methylenetetrahydrofolate Reductase (MTHFR) 677C/T Variant and Atypical Antipsychotic (AAPs) Associated Metabolic Syndrome and Insulin Resistance in Subjects with Schizophrenia
Atomoxetine For Children and Adolescents with ADHD and Reading Disorders
Atomoxetine Treatment for ADHD: Young Adults Compared With Older Adults
Augmentation of Aripiprazole with Low-Dose Clozapine
Bupropion Augmentation Versus Usual Care in the Treatment of Patients with Treatment-Resistant Depression
Cardiac arrest secondary to amphetamine/dextroamphetamine abuse: a case report
Cardiovascular monitoring of atypical antipsychotic pharmacotherapy in schizophrenia and bipolar spectrum disorders
Clozapine treatment in a patient with a persistently low neutrophil count
Clozapine Underutilization and Discontinuation in African-Americans Due to Leucopenia
Comparative Safety and Tolerability of Alzheimer's Disease Treatments
Comparison of observed outcomes with intramuscular haloperidol, olanzapine, and ziprasidone for acute agitation in the emergency department
Complete Resolution of Olanzapine-Induced Diabetic Ketoacidosis
Correlation of Anxiety with Depression and Quality of Life in People with Epilepsy: Symptomatic Improvement after Lamotrigine Adjunctive Therapy
Demonstrating Proof of Principle and Finding the Right Dose: The Role of CSF ‘Dynabridging’ Studies
DEVELOPMENT AND IMPLEMENTATION OF A PHARMACIST BASED DIABETES EDUCATION AND SELF-MANAGEMENT PROGRAM IN AN INPATIENT PSYCHIATRIC HOSPITAL
Development and implementation of a pharmacist-run medication education program focusing on adherence to antipsychotic agents: a descriptive study
DEVELOPMENT OF A WEB-BASED CLINICIAN LEARNING PROGRAM FOR ALGORITHM-BASED CARE OF ADULTS WITH MAJOR MENTAL ILLNESSES: THE WEB-TEXAS MEDICAID ALGORITHM PROJECT (WEB-TMAP)
Differential Antidepressant Symptom Efficacy: Placebo-controlled Comparisons of Duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram)
Differential Antidepressant Symptom Efficacy: Placebo-controlled Comparisons of Duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram)
Does Gender Affect Valproate Pharmacokinetics?
Early Symptom Change Prediction of Remission in Depression Treatment
ECONOMIC BURDEN OF ALCOHOLISM AND ALCOHOL ABUSE IN A US MANAGED-CARE SETTING
Effectiveness and tolerability of pregabalin for dystonia and other hyperkinetic movement disorders (HMDs): an open-label exploratory study
Effects of Aripiprazole on Reproductive Endocrine Parameters
Efficacy and safety of lacosamide in painful distal diabetic neuropathy
Efficacy and Safety of Rasagiline as adjunct therapy in Parkinson disease (PD) patients receiving levodopa and entacapone
Efficacy and Tolerability of Ropinirole in the Treatment of Restless Legs Syndrome (RLS)
EFFICACY OF ACAMPROSATE IN PREVENTION OF SEVERE RELAPSE: ANALYSIS OF THE DATABASE FROM 16 CONTROLLED STUDIES
Evaluation of an Inpatient Psychopharmacology Consult Service
Evaluation of Atypical Antipsychotic Polypharmacy in an Acute Inpatient Psychiatric Facility
Evaluation of Intramuscular Olanzapine Use for Acute Agitation in a General Medical Hospital
Evaluation of the Role of Family History in the Development of Diabetes Among Patients With Schizophrenia Receiving Clozapine or Olanzapine
First do not do harm. Drugs withdrawal in the management of a severely ill woman
Forensic Medication Usage Evaluations as Evidence of Treatment in a Patient's Best Medical Interest
FORMULATION CONVERSION FROM DIVALPROEX SODIUM EC TO DIVALPROEX SODIUM ER: EFFECTS ON ADHERENCE
Frequency of CYP2D6, CYP2C19 and ABCB1 Variant Alleles in Treatment Sensitive and Treatment Resistant Psychiatric Patients
Functional, Clinical, and Economic Ramifications of Early Non-Response to Antipsychotics in the Naturalistic Treatment of Schizophrenia
Galantamine Does Not Significantly Effect Positive or Negative Symptoms in Patients with Schizophrenia
Genetic predictors of response to lithium in bipolar patients with euphoric and dysphoric mania: association to NTRK2, GRK3, and Bcl-2
Geriatric Depression Over the Decades: An evaluation of the incidence and treatment of depression in a geriatric primary care clinic
HEALTHCARE BURDEN OF PATIENTS WITH ALCOHOL DEPENDENCE SYNDROME
Hypomania with Agitation Associated with Varenicline Use in Bipolar II Disorder
Impact of omega-3 fatty acid (fish oil) supplementation on the lipid panel of patients receiving atypical antipsychotics
Implementation of a Delirium Screening Protocol in an Intensive Care Unit in a Community Hospital: Incidence and Associated Outcomes
Implementation of Prescriber Profile Reports in a Community Mental Health Organization
IMPROVEMENTS IN SYMPTOMS OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER IN SCHOOL-AGED CHILDREN WITH LISDEXAMFETAMINE DIMESYLATE AND EXTENDED-RELEASE MIXED AMPHETAMINE SALTS VERSUS PLACEBO IN A CLASSROOM ANALOG STUDY
Incidence of Abnormal Metabolic Parameters and Weight Gain Induced by Atypical Antipsychotics in Elderly Dementia Patients
Increased Clozapine Concentration in a Patient with Pneumonia
INITIATIVES TO INCREASE PHARMACIST PARTICIPATION IN ADMISSION MEDICATION RECONCILIATION IN A PSYCHIATRIC ACUTE CARE INPATIENT UNIT
LACK OF RASAGILINE – TYRAMINE INTERACTION IN LEVODOPA-NAIVE PATIENTS WITH PARKINSON DISEASE
Long-Term Effects of Aripiprazole on the Lipid Profiles of Patients With Bipolar I Disorder
Long-Term Safety and Efficacy of Memantine Treatment in Moderate to Severe Alzheimer’s Disease: Results from a Three-Year Trial
Long-Term Symptomatic Remission in Schizophrenia Patients
Long-term use of the rotigotine transdermal patch in early-stage Parkinson’s disease
Measuring The Improvement of Cognition in patients receiving clozapine ODT Using Positive and Negative Symptom Scale- A Pilot Study
Medication Use Evaluation of Risperidal Consta® in a VA outpatient mental health clinic
Metoclopramide-mediated hyperprolactinemia in a developmentally disabled adult woman: a case report
Multi-Step Approach to Educate Healthcare Workers on Antipsychotic Polypharmacy: Impact on Prescribing Practices
Olanzapine-Fluoxetine Combination Versus Lamotrigine for Bipolar I Depression: Quality of Life Outcome Analysis
Olanzapine-Induced Neutropenia: A Case Report
ONCE-DAILY DOSING, OVER A LARGE DOSE RANGE, IS APPROPRIATE FOR EXTENDED-RELEASE DIVALPROEX, BUT NOT FOR ENTERIC-COATED, DELAYED-RELEASE DIVALPROEX: EVIDENCE VIA COMPUTER SIMULATIONS AND IMPLICATIONS FOR EPILEPSY THERAPY
PALIPERIDONE ER IN SCHIZOPHRENIA PATIENTS PREVIOUSLY RECEIVING RISPERIDONE
PALIPERIDONE EXTENDED-RELEASE IN PATIENTS WITH SCHIZOPHRENIA PREVIOUSLY TREATED WITH ANTIPSYCHOTIC POLYPHARMACY
Personal Digital Assistant Based Pharmaceutical Care Consultation Documentation in a Regional State Psychiatric Facility
Polypharmacy, Antipsychotic Dosage, and Discontinuation of Antipsychotic Therapy Among Patients with Bipolar Disorder
Post-Stroke Pseudobulbar Affect Treated with Dextromethorphan/Quinidine
PRE-SCREENING OF METABOLIC ABNORMALITIES AND HYPERTENSION AMONG PATIENTS WITH SERIOUS MENTAL ILLNESS AND CONCURRENT ANTIPSYCHOTIC THERAPY
Predictors of Bipolar Disorder in Patients Diagnosed With Major Depression in a Privately Insured Population
Predictors of physiological response to mental stress in smokers
Prescribing Patterns in Children and Adolescents with Bipolar Disorder
Prevalence of erectile dysfunction among patients taking different antiepileptic medications
PREVALENCE OF INACCURATELY LABELED PSYCHOTROPIC ALLERGIES WITHIN A STATE PSYCHIATRIC FACILITY
RASAGILINE DOES NOT PROMOTE A TYRAMINE PRESSOR RESPONSE IN LEVODOPA-TREATED PATIENTS WITH PARKINSON DISEASE
Rehospitalization Rates after Inpatient Discharge on Haloperidol Decanoate Compared to Risperidone Long-Acting Injection
Relationship of Supervision, Side Effects and Complexity to Adherence with Antipsychotic Treatment
Retrospective Review of Patients Treated for Depression Undergoing Gastric Bypass Surgery: A Focus on Medications
Ropinirole Improves Mood and Anxiety Symptoms in Patients with Restless Legs Syndrome (RLS)
Safety of Rasgiline in Parkinson disease (PD) patients receiving serotonin reuptake inhibitors (SSRI)
Selegiline Transdermal System for the Treatment of Major Depressive Disorder: A Symptom-based Analysis of Placebo-Controlled Efficacy Trials
Serotonin transporter promoter insertion/deletion subtypes, intron 2 VNTR, and Ile425 polymorphisms and SSRI-associated sexual dysfunction
Sexual Dysfunction in Patients With Major Depressive Disorder: A Comparison Between Selegiline Transdermal System 6 mg/24 hr and Placebo Using a Patient-rated Scale
Six-month rehospitalization rates of first-episode psychosis patients discharged on newer atypical antipsychotics versus olanzapine and risperidone
Steady State Concentrations after Standard and Higher Doses of Oral Olanzapine in Acutely Ill Patients with Schizophrenia or Schizoaffective Disorder with Suboptimal Prior Response
Tamoxifen-exacerbated delusions: a case report
The biopharmaceutics of divalproex sodium extended-release tablets vs. other formulations: Top ten pharmacokinetic essentials for the clinician
The long term metabolic effects of treatment with psychoactive medication in male children and adolescents: Baseline demographics
The misuse of fentanyl patch in a psychiatric patient
The Pharmacogenomics of Antidepressant Tolerance
The Relationship Between Functional Outcomes and Treatment of Anxious and Painful Somatic Symptoms in Patients with Generalized Anxiety Disorder
TIME TO ONSET OF ACTIVITY AND RESPONSE ON INDIVIDUAL CAPS-SX17 ITEMS IN PATIENTS WITH POSTTRAUMATIC STRESS DISORDER TREATED WITH VENLAFAXINE XR: A POOLED ANALYSIS
Tolerability of switching from an oral dopamine agonist to transdermal rotigotine in Parkinson’s disease
Transdermal Rotigotine: Evaluation of Efficacy and Continuous Drug Delivery in Parkinson’s Disease
USE OF BUPROPION IN THE VETERAN POPULATION WITH POSTTRAUMATIC STRESS DISORDER
Utility of a CommunityZero Website to Enhance Communication During a Clinical Pharmacy Rotation
Variability of Olanzapine Plasma Levels and the Influence of Drug Interactions